Sleep apnea pill maker Apnimed files for US IPO as biotech market revives
July 10 (Reuters) - Apnimed, a late-stage clinical pharmaceutical company, filed for an initial public offering in the U.S. on Friday. The biotech sec...
Read the full articleSyndicated Content18h ago
You might also wanna read
Sleep apnea pill maker Apnimed files for US IPO as biotech market revives
July 10 (Reuters) - Apnimed, a late-stage clinical pharmaceutical company, filed for an initial public offering in the U.S. on Friday. The b
KELO-AM·18h ago
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
stocktitan.net·1mo ago
Obesity biotech Kalohexis files confidential IPO
Obesity biotech Kalohexis files confidential IPO Phil.Taylor Tue, 07/07/2026 - 13:46
pharmaphorum·4d ago
Scribe notes down IPO ambition to fund lipid-lowering genetic meds through clinical trials
Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through c
Fierce Biotech·8d ago
Prodia Diagnostic Line Makes Indonesia Stock Exchange Debut
The medical device manufacturer PT Prodia Diagnostic Line Tbk. (PRDL) conducted an IPO on the Indonesia Stock Exchange.
Tempo·2d ago
Nuvation Bio Inc. Files Form 8-K with SEC Regarding Material Corporate Event
UNITED STATES
sec.gov·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.